Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG103 in non-diabetic overweight or obesity
NCT05997576Phase 3Completed
- Sponsor
- CSPC Baike Biopharmaceutical
- Start
- Nov 2023
- Primary completion
- Feb 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of GX-G6 in Overweight, obesity, sponsored by CSPC Baike Biopharmaceutical. Started Nov 2023; status: completed.
02
Drugs
GX-G6
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on NCT05997576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05997576.